SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-17-062524
Filing Date
2017-10-17
Accepted
2017-10-17 15:44:46
Documents
2
Group Members
BRIAN W. SCANLANGREGORY P. SARGENJAMES J. EGANROGER FARLEYRONIN TRADING, LLCSAIID ZARRABIANSTEPHEN WHITESW INVESTMENT MANAGEMENT LLCSWIM PARTNERS LP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a17-24113_1sc13da.htm SC 13D/A 244485
2 EX-99.1 a17-24113_1ex99d1.htm EX-99.1 25365
  Complete submission text file 0001104659-17-062524.txt   271566
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Subject) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: SC 13D/A | Act: 34 | File No.: 005-37393 | Film No.: 171140708
SIC: 2834 Pharmaceutical Preparations

Mailing Address 230 SOUTH LASALLE STREET 400 CHICAGO IL 60604
Business Address
STAFFORD JOHN S III (Filed by) CIK: 0001218981 (see all company filings)

Type: SC 13D/A